phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Dual Targeting Approach Improves Immunotherapy Response in Glioblastoma

* Glioblastoma is a deadly brain cancer that doesn't respond well to immunotherapy * Blocking two key "don't eat me" signals at the same time improved response to immunotherapy in glioblastoma models * Targeting immune "first responders" is a promising strategy to improve antitumor response

March 12, 2026


March 13 2026

March 12 2026

March 11 2026

March 10 2026

March 9 2026

March 8 2026

March 7 2026

March 6 2026

March 5 2026

March 4 2026

March 3 2026

March 2 2026

March 1 2026

February 28 2026

February 27 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy